Clinical efficacy of mild therapeutic hypothermia with different rewarming time on neonatal hypoxic-ischemic encephalopathy: a prospective randomized controlled study.
10.7499/j.issn.1008-8830.2211158
- Author:
Yu-Xin LIN
1
;
Xiao FENG
1
;
Yi-Dan ZHANG
1
;
Wan-Rong HONG
1
;
Hong-Ying ZHAO
1
Author Information
1. Department of Pediatrics, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.
- Publication Type:Journal Article
- Keywords:
Clinical efficacy;
Hypoxic-ischemic encephalopathy;
Mild therapeutic hypothermia;
Neonate;
Rewarming
- MeSH:
Infant, Newborn;
Infant;
Child;
Humans;
Child, Preschool;
Prospective Studies;
Rewarming;
Hypoxia-Ischemia, Brain/therapy*;
Hypothermia, Induced/methods*;
Treatment Outcome;
Electroencephalography/methods*
- From:
Chinese Journal of Contemporary Pediatrics
2023;25(4):350-356
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To investigate the clinical efficacy of mild therapeutic hypothermia (MTH) with different rewarming time on neonatal hypoxic-ischemic encephalopathy (HIE).
METHODS:A prospective study was performed on 101 neonates with HIE who were born and received MTH in Zhongshan Hospital, Xiamen University, from January 2018 to January 2022. These neonates were randomly divided into two groups: MTH1 group (n=50; rewarming for 10 hours at a rate of 0.25°C/h) and MTH2 group (n=51; rewarming for 25 hours at a rate of 0.10°C/h). The clinical features and the clinical efficacy were compared between the two groups. A binary logistic regression analysis was used to identify the factors influencing the occurrence of normal sleep-wake cycle (SWC) on amplitude-integrated electroencephalogram (aEEG) at 25 hours of rewarming.
RESULTS:There were no significant differences between the MTH1 and MTH2 groups in gestational age, 5-minute Apgar score, and proportion of neonates with moderate/severe HIE (P>0.05). Compared with the MTH2 group, the MTH1 group tended to have a normal arterial blood pH value at the end of rewarming, a significantly shorter duration of oxygen dependence, a significantly higher proportion of neonates with normal SWC on aEEG at 10 and 25 hours of rewarming, and a significantly higher Neonatal Behavioral Neurological Assessment score on days 5, 12, and 28 after birth (P<0.05), while there was no significant difference in the incidence rate of rewarming-related seizures between the two groups (P>0.05). There were no significant differences between the two groups in the incidence rate of neurological disability at 6 months of age and the score of Bayley Scale of Infant Development at 3 and 6 months of age (P>0.05). The binary logistic regression analysis showed that prolonged rewarming time (25 hours) was not conducive to the occurrence of normal SWC (OR=3.423, 95%CI: 1.237-9.469, P=0.018).
CONCLUSIONS:Rewarming for 10 hours has a better short-term clinical efficacy than rewarming for 25 hours. Prolonging rewarming time has limited clinical benefits on neonates with moderate/severe HIE and is not conducive to the occurrence of normal SWC, and therefore, it is not recommended as a routine treatment method.
